Top

Published in:

Open Access 01-02-2011 | Editorial

Dispute settlement understanding on the use of BOTOX^® in chronic migraine

Author: Paolo Martelletti

Published in: The Journal of Headache and Pain | Issue 1/2011

Excerpt

Two important scientists such as Jes Olesen and Peer Tfelt-Hansen have recently lodged a complaint regarding the hypothetical weakness of data presented to the Medicines and Healthcare Products Regulatory Agency for the extension of BOTOX^® registration also for chronic migraine (CM) in UK [1]. Besides the institutional reply given by Jennifer Kyne from the above-mentioned agency [2], I believe a discussion should develop around the intricate matter of CM’s classification, especially if such medical condition is considered separately from a rapidly expanding pathology such as medication overuse headache (MOH) [3‐6]. …

Olesen J, Tfelt-Hansen P (2010) Licence for Botox in so-called chronic migraine. Lancet 376:1825–1826, 21111904, 10.1016/S0140-6736(10)62165-4CrossRefPubMed

Kyne J (2010) Response from MHRA. Lancet 376:1826, 10.1016/S0140-6736(10)62166-6CrossRef

Negro A, D’Alonzo L, Martelletti P (2010) Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med 5(1):S13–S19, 20865469, 10.1007/s11739-010-0457-7CrossRefPubMed

Hagen K, Jensen R, Bøe MG, Stovner LJ (2010) Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 11:373–377, 20473701, 10.1007/s10194-010-0221-4PubMedCentralCrossRefPubMed

Allena M, Katsarava K, Nappi G, The COMOESTAS Consortium (2009) From-drug-induced headache to medication overuse headache. A short-epidemiological review, with a focus on Latin American countries. J Headache Pain 10:71–76, 19238511, 10.1007/s10194-009-0101-yPubMedCentralCrossRefPubMed

Rossi P, Jensen R, Nappi G, Allena M, The COMOESTAS Consortium (2009) A narrative review on the management of medication overuse headache: the step road from experience to evidence. J Headache Pain 10:407–417, 19802522, 10.1007/s10194-009-0159-6PubMedCentralCrossRefPubMed

Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P (2010) Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 7:81–91, 10.2147/NDT.S8467CrossRef

Ferrari A, Tiraferri I, Neri L, Sternieri E (2010) Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain. doi:10.1007/s10194-010-0258-4

Gentile G, Missori S, Borro M, Sebastianelli A, Simmaco M, Martelletti P (2010) Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain 11:151–156, 20213484, 10.1007/s10194-010-0202-7, 1:CAS:528:DC%2BC3cXjtlalsrg%3DPubMedCentralCrossRefPubMed

10.

Gentile G, Borro M, Lala N, Missori S, Simmaco M, Martelletti P (2010) Genetic polimorphysms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 11:431–435, 20652353, 10.1007/s10194-010-0241-0, 1:CAS:528:DC%2BC3cXhtFOqsr7KPubMedCentralCrossRefPubMed

11.

Gentile G, Borro M, Simmaco M, Missori S, Lala N, Martelletti P (2011) Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy. Expert Opin Drug Metab Toxicol 7:39–47, 21142809, 10.1517/17425255.2011.538680, 1:CAS:528:DC%2BC3cXhsFKqurrFCrossRefPubMed

12.

Stovner LJ, Tronvik E, Hagen K (2009) New drugs for migraine. J Headache Pain 10:395–406, 19795182, 10.1007/s10194-009-0156-9, 1:CAS:528:DC%2BD1MXhsVGlsbvOPubMedCentralCrossRefPubMed

13.

Farinelli I, De Filippis S, Coloprisco G, Missori S, Martelletti P (2009) Future drugs for migraine. Intern Emerg Med 4:367–373, 19551474, 10.1007/s11739-009-0273-0CrossRefPubMed

14.

Martelletti P (2006) The road ahead for chronic headache patients. J Headache Pain 7:317–319, 17058036, 10.1007/s10194-006-0341-zPubMedCentralCrossRefPubMed

15.

Farinelli I, Coloprisco G, De Filippis S, Martelletti P (2006) Long-term benefits of botulinum toxin type A (BOTOX^®) in chronic daily headache: a five-year long experience. J Headache Pain 7:407–412, 17149565, 10.1007/s10194-006-0344-9, 1:CAS:528:DC%2BD2sXkt1Sjsw%3D%3DPubMedCentralCrossRefPubMed

16.

Farinelli I, Dionisi I, Martelletti P (2010) Rehabilitating chronic migraine complicated by medication overuse headaches: how we can prevent relapse? Intern Emerg Med. doi:10.1007/s11739-010-0410-9

17.

Askenazy A (2010) Botulinum toxin type A for chronic migraine. Current Neurol Neurosci Rep 10:140–146, 10.1007/s11910-010-0087-5CrossRef

18.

Freitag FG (2010) Importance of botulinum toxin for prevention of migraine. Expert Rev Neurother 10:339–340, 20187855, 10.1586/ern.10.11, 1:CAS:528:DC%2BC3cXis1alu7c%3DCrossRefPubMed

19.

Chen S-P, Fuh J-L, Wang S-J (2010) OnabotulinumtoxinA: preventive treatment for chronic migraine. Curr Pain Headache Rep. doi:10.1007/s11916-010-0150-6

20.

Cady RK (2010) Onabotulinumtoxin A (botulinum toxin type-A) in the prevention of migraine. Expert Opin Biol Ther 10:289–298, 20088719, 10.1517/14712590903586221, 1:CAS:528:DC%2BC3cXovVCqtA%3D%3DCrossRefPubMed

Title: Dispute settlement understanding on the use of BOTOX® in chronic migraine
Author: Paolo Martelletti
Publication date: 01-02-2011
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-010-0288-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dispute settlement understanding on the use of BOTOX^® in chronic migraine

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Referred pain from myofascial trigger points in head and neck–shoulder muscles reproduces head pain features in children with chronic tension type headache

Acknowledgment to referees

What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information?

Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions

Tension-type headache and sleep apnea in the general population

Overview of diagnosis and management of paediatric headache. Part I: diagnosis